Real World Effectiveness, Persistence, Tolerability, and Safety of Ofatumumab in Clinical Practice
Clinical trial NCT06737419 · COMPLETED
Trial details
- NCT number
- NCT06737419
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-06-09
- Primary completion
- 2024-02-05
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.